Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964782 · ClinicalTrials.gov registry record · Phase 4
The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation
A Phase 4 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT00964782: Completed Phase 4 study, sponsored by Milton S. Hershey Medical Center.
NCT00964782 is a Phase 4 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 17 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00964782, a Phase 4 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The study will test the hypothesis that a single dose of sildenafil can increase the exercise capacity of pediatric patients with a Fontan Circulation.
Primary Outcome
A change in exercise capacity measured via maximum oxygen consumed during exercise (VO2). The measurement will be obtained from the Exercise Stress Test
Interventions
- DRUG Placebo
- DRUG Placebo 2
- DRUG Sildenafil
- DRUG Sildenafil 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-05-24 |
| Phase | Phase 4 |
What the finished NCT00964782 record still lists
NCT00964782 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00964782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00964782 about?
NCT00964782 is a clinical study titled "The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation". The study will test the hypothesis that a single dose of sildenafil can increase the exercise capacity of pediatric patients with a Fontan Circulation.
What is the current status of trial NCT00964782?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2009-08. Estimated completion is 2012-05-24.
What interventions are being tested in trial NCT00964782?
The interventions under investigation include: Placebo (DRUG), Placebo 2 (DRUG), Sildenafil (DRUG), Sildenafil 2 (DRUG).
Who is sponsoring clinical trial NCT00964782?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00964782's enrollment target sits among peer trials
17 1854th of 2000 higher than 132 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia